Latest News


Funding paves the way for crucial new research programs.

A large collection of research projects will get underway at Royal North Shore Hospital following generous funding through the Ramsay Research Grants Program. The scheme has directed more than $10 million to research on the campus over the last 19 years. This year over $700,000 is being invested in a total of 14 innovative studies, all aimed at improving our research impact and the care .....
Read more

Category: Awards, Research Excellence

High-profile clinician researcher recruited to key research position.

Professor Bruce Robinson has been appointed the NSLHD Chair of Research in an important step towards strengthening research expertise across the district. Professor Robinson, a Kolling Institute researcher, will step into the newly created role this month, bringing a tremendous wealth of research, clinical and policy experience with him. Bruce will be responsible for providing leadership.....
Read more

Category: Research Excellence

Researchers develop test to identify the severity of kidney disease.

We may soon have a safer approach to diagnosing and measuring the progression of chronic kidney disease following new research by the team from the Kolling Institute’s Renal Research Laboratory. The condition is a global health issue, which now affects more than 13 per cent of the worldwide population. Chronic kidney disease is a progressive disease that leads to end-stage kidney failur.....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

The Kolling announces new Academic Director .

Professor Jim Elliott has been appointed the Kolling Institute’s new Academic Director. Professor Elliott brings a wealth of experience to the position including a research career spanning more than two decades. He is recognised as a global expert in neck pain and whiplash injuries and leads large scale, multi-centre projects involving collaborators from across the globe. During a period.....
Read more

Researchers investigate if stem cells can reverse osteoarthritis damage .

Our researchers are seeking participants for a large-scale clinical trial pioneering the use of stem cells to treat and potentially cure osteoarthritis. The disease is now one of the leading causes of disability in the world, affecting around three million people in Australia alone. Royal North Shore Hospital rheumatologist Professor David Hunter is leading the two-year trial which is re.....
Read more

Category: Musculoskeletal Research, New Treatment

Researchers seeking closer ties with industry .

Researchers at the Kolling Institute are increasingly forging partnerships with industry, with the collaborative efforts accelerating improvements in patient care. One team which has particularly benefitted from a strong relationship with industry partners is the diverse group from the Murray Maxwell Biomechanics Laboratory. Director, Associate Professor Liz Clarke is encouraging others .....
Read more

Category: Funding support, Research Excellence

Innovative research on show.

An impressive group of emerging leaders addressed the Kolling’s Neuroscience and Pain Showcase, sharing details of their diverse and exciting research projects. With a broad range of expertise in this field, the showcase involved representatives from the pain management and rehabilitations teams, as well as the ageing, mental health, neurogenetics and neuromuscular imaging groups. The ea.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Remarkable service recognised in Queen’s birthday honours.

We would like to congratulate our Kolling Institute researcher Professor Sarah Hilmer who’s been awarded an AM for her service to clinical and geriatric pharmacology as part of the Queen’s birthday honours. Professor Hilmer has worked as the Head of Clinical Pharmacology and as a geriatrician at Royal North Shore Hospital since 2005. Her research and clinical expertise is respected both .....
Read more

Category: Awards, Research Excellence

Championing precision medicine for children living with arthritis.

The largest study in Australia into the treatment of juvenile arthritis may pave the way for a unique approach to care for those with the disabling condition and dramatically improve outcomes. The Medical Research Future Fund will invest $2.5 million in the A3BC for Kids project which will involve researchers from the Kolling Institute and the University of Sydney in collaboration with t.....
Read more

Category: Funding support, Musculoskeletal Research

Ground breaking approach to emergency care in NSW to be tested.

New funding will see a large-scale project launched across NSW to significantly improve patient outcomes and experiences in Emergency Departments. Chief investigator and Kolling Institute researcher Professor Margaret Fry said more than $2.8 million will be invested in the EPIC-START program, giving patients better access to early evidence-based treatment pathways. 30 Emergency Departmen.....
Read more

Category: New Treatment, Research Excellence